424 related articles for article (PubMed ID: 17608852)
21. Matrix metalloprotease polymorphisms are associated with gas transfer in alpha 1 antitrypsin deficiency.
McAloon CJ; Wood AM; Gough SC; Stockley RA
Ther Adv Respir Dis; 2009 Feb; 3(1):23-30. PubMed ID: 19293200
[TBL] [Abstract][Full Text] [Related]
22. Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer.
Su L; Zhou W; Asomaning K; Lin X; Wain JC; Lynch TJ; Liu G; Christiani DC
Carcinogenesis; 2006 May; 27(5):1024-9. PubMed ID: 16311244
[TBL] [Abstract][Full Text] [Related]
23. A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer.
Xu E; Lai M; Lv B; Xing X; Huang Q; Xia X
Biochem Biophys Res Commun; 2004 Nov; 324(3):999-1003. PubMed ID: 15485653
[TBL] [Abstract][Full Text] [Related]
24. Genetic polymorphisms of MMP1, MMP3 and MMP7 gene promoter and risk of colorectal adenoma.
Lièvre A; Milet J; Carayol J; Le Corre D; Milan C; Pariente A; Nalet B; Lafon J; Faivre J; Bonithon-Kopp C; Olschwang S; Bonaiti-Pellié C; Laurent-Puig P;
BMC Cancer; 2006 Nov; 6():270. PubMed ID: 17125518
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinase-1 and -9 promoter polymorphisms are not associated with an increased risk of uterine leiomyomas in a Japanese population.
Takemura N; Yoshida S; Kennedy S; Deguchi M; Ohara N; Maruo T
J Soc Gynecol Investig; 2006 Apr; 13(3):232-6. PubMed ID: 16638593
[TBL] [Abstract][Full Text] [Related]
26. Matrix metalloproteinase (MMP) -2, -7 and -9 promoter polymorphisms in colorectal cancer in ethnic Kashmiri population - A case-control study and a mini review.
Banday MZ; Sameer AS; Mir AH; Mokhdomi TA; Chowdri NA; Haq E
Gene; 2016 Sep; 589(1):81-89. PubMed ID: 27222481
[TBL] [Abstract][Full Text] [Related]
27. Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness.
Ghilardi G; Biondi ML; Mangoni J; Leviti S; DeMonti M; Guagnellini E; Scorza R
Clin Cancer Res; 2001 Aug; 7(8):2344-6. PubMed ID: 11489811
[TBL] [Abstract][Full Text] [Related]
28. [Association of functional polymorphisms in matrix metalloproteinase-2 (MMP-2) and MMP-9 genes with risk of gastric cancer in a Chinese population].
Zhang XM; Miao XP; Xiong P; Yu CY; Tan W; Qu SN; Sun T; Zhou YF; Lin DX
Ai Zheng; 2004 Nov; 23(11):1233-7. PubMed ID: 15522165
[TBL] [Abstract][Full Text] [Related]
29. [Study on matrix metalloproteinase 1, 9, 12 polymorphisms and susceptibility to chronic obstructive pulmonary disease among Han nationality in northern China].
Zhang RB; He QY; Yang RH; Lu BB; Liu YJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Nov; 26(11):907-10. PubMed ID: 16676616
[TBL] [Abstract][Full Text] [Related]
30. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with mortality in haemodialysis patients.
Cozzolino M; Biondi ML; Galassi A; Turri O; Brancaccio D; Gallieni M
Nephrol Dial Transplant; 2009 Jul; 24(7):2207-12. PubMed ID: 19221176
[TBL] [Abstract][Full Text] [Related]
31. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.
Przybylowska K; Kluczna A; Zadrozny M; Krawczyk T; Kulig A; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J
Breast Cancer Res Treat; 2006 Jan; 95(1):65-72. PubMed ID: 16267613
[TBL] [Abstract][Full Text] [Related]
32. Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer.
Padala C; Tupurani MA; Puranam K; Gantala S; Shyamala N; Kondapalli MS; Gundapaneni KK; Mudigonda S; Galimudi RK; Kupsal K; Nanchari SR; Chavan U; Chinta SK; Mukta S; Satti V; Hanumanth SR
PLoS One; 2017; 12(9):e0184448. PubMed ID: 28961241
[TBL] [Abstract][Full Text] [Related]
33. Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma.
Zhou G; Zhai Y; Cui Y; Qiu W; Yang H; Zhang X; Dong X; He Y; Yao K; Zhang H; Peng Y; Yuan X; Zhi L; Zhang X; He F
Hum Mutat; 2007 Nov; 28(11):1091-7. PubMed ID: 17607721
[TBL] [Abstract][Full Text] [Related]
34. Genetic polymorphisms of matrix metalloproteinase 12 and 13 genes are implicated in endometriosis progression.
Borghese B; Chiche JD; Vernerey D; Chenot C; Mir O; Bijaoui G; Bonaiti-Pellié C; Chapron C
Hum Reprod; 2008 May; 23(5):1207-13. PubMed ID: 18308831
[TBL] [Abstract][Full Text] [Related]
35. Genetic polymorphisms of matrix metalloproteinases: susceptibility and prognostic implications for prostate cancer.
Dos Reis ST; Pontes J; Villanova FE; Borra PM; Antunes AA; Dall'oglio MF; Srougi M; Leite KR
J Urol; 2009 May; 181(5):2320-5. PubMed ID: 19303106
[TBL] [Abstract][Full Text] [Related]
36. Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosis.
Bradbury PA; Zhai R; Hopkins J; Kulke MH; Heist RS; Singh S; Zhou W; Ma C; Xu W; Asomaning K; Ter-Minassian M; Wang Z; Su L; Christiani DC; Liu G
Carcinogenesis; 2009 May; 30(5):793-8. PubMed ID: 19321798
[TBL] [Abstract][Full Text] [Related]
37. The association of MMP-1, -3 and -9 genotypes with the prognosis of HCV-related hepatocellular carcinoma patients.
Okamoto K; Mandai M; Mimura K; Murawaki Y; Yuasa I
Res Commun Mol Pathol Pharmacol; 2005; 117-118():77-89. PubMed ID: 18426080
[TBL] [Abstract][Full Text] [Related]
38. Matrix metalloproteinase-1 promoter is associated with body mass index in Korean population with aged greater or equal to 50 years.
Nho YK; Ha E; Yu KI; Chung JH; Wook NC; Chung IS; Lee MY; Shin DH
Clin Chim Acta; 2008 Oct; 396(1-2):14-7. PubMed ID: 18602909
[TBL] [Abstract][Full Text] [Related]
39. The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma.
Zhang J; Jin X; Fang S; Wang R; Li Y; Wang N; Guo W; Wang Y; Wen D; Wei L; Dong Z; Kuang G
Carcinogenesis; 2005 Oct; 26(10):1748-53. PubMed ID: 15930031
[TBL] [Abstract][Full Text] [Related]
40. Matrix metalloproteinase (MMP) -1, -2, -3 and -9 promoter polymorphisms in colorectal cancer.
Elander N; Söderkvist P; Fransén K
Anticancer Res; 2006; 26(1B):791-5. PubMed ID: 16739355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
